Mumps

Reportable by Providers and Laboratories

About this Reportable Disease

Infectious agent: Mumps virus

Description of illness:Mumps is a vaccine-preventable systemic viral illness that is transmitted through droplets when people cough or sneeze, with an average incubation period of 16-18 days (range: 12-25 days). The classic mumps symptom is swelling of one or more of the salivary glands, often the parotid gland, located around the jawline. Other common symptoms that may precede parotitis include fever, headache, muscle aches, tiredness. Complications may include orchitis (swollen testicles), oophritis (swollen ovaries), mastitis, pancreatitis or meningitis. Up to one in three cases do not exhibit any salivary gland swelling, and may have no symptoms or a mild respiratory illness. Symptoms tend to decrease after one week and usually resolve within 10 days. Outbreaks can occur in highly vaccinated populations, especially in settings where groups have prolonged close contact, such as colleges.

Interactive Disease Data


Laboratory Reporting for this Disease

Mumps Virus PCR

TEST NAME Mumps Virus PCR
DISEASE/DISORDER Mumps Virus
ALTERNATE NAME(S) None
METHODOLOGY PCR
SPECIAL INSTRUCTIONS
  • PRIOR CONSULTATION REQUIRED. 
  • REQUESTED THROUGH CONSULTATION WITH EPIDEMIOLOGY ONLY.  
  • Contact CEDEP prior to submission.
ORDERING INFORMATION TDH DLS Requisition:  PH-4182 Clinical Submission Requisition Form

Specimen Requirements

Patient Preparation

  • None
Specimen Collection
  • Oral/buccal swab in 1-3mL Viral Transport Media
  • Throat swab in 1-3mL Viral Transport Media
Specimen Labeling
  • Specimen should be labeled with at least two unique patient identifiers and match the accompanying PH-4182 Clinical Submission Form.
Specimen Processing
  • None
Specimen Storage and Preservation
  • Specimens may be stored at 2 - 8°C for up to 5 days after collection.
  • If testing will be delayed more than 5 days, specimens should be frozen at            (-70)°C or colder.
Specimen Transportation
  • Ship specimens at 2 - 8°C with cold packs.
  • Frozen specimens should be shipped on Dry Ice.
  • Specimen must be placed in an individual biohazard bag with absorbent material  and should be shipped to the laboratory on the day of collection whenever possible. 
  • All infectious substance shipments must conform to U.S. Department of Transportation (DOT) Hazardous Materials Regulations (HMR 49 C.F.R. Parts 171-180). 
Specimen Acceptability and Rejection
  • Unsatisfactory specimens include, but may not be limited to:

- The specimen was broken or leaked in transit

- No specimen was in the container submitted

- Improper specimen type submitted

- Specimens received at improper temperature

- Specimens received without documentation of consultation

Testing Location
  • Nashville

Laboratory Reporting

Reporting requirements apply to all laboratories located within Tennessee, as well as laboratories outside of Tennessee that test residents of Tennessee, including laboratories located within healthcare facilities. Healthcare providers and laboratories in the same healthcare facility both have a duty to report. The type of organisms and analytes laboratories must report to TDH for 2026 are indicated, and there are several ways laboratories can report results to TDH.

Information about this Reportable Disease for Healthcare Providers

Clinical Summary

  • It’s a contagious viral infection caused by the mumps virus (a member of the Paramyxoviridae family) that primarily affects the salivary glands. 
  • Typical infection presents with fever, headache, muscle aches, tiredness, and swelling/tenderness of the parotid (jaw/cheek) glands. 
  • Incubation period averages about 16-18 days (range ~12-25 days), and while most recover fully in ~2 weeks, complications (e.g., orchitis, meningitis, hearing loss) can occur. 
  • There is no specific antiviral treatment; management is supportive (rest, fluids, pain relief) and prevention is via the two-dose MMR vaccine.

Healthcare Provider Reporting

Healthcare reporting requirements apply to all providers located within Tennessee, as well as providers whose patients reside in Tennessee.

Providers must report cases of all diseases and conditions listed through one of these methods:

• Mail or fax a completed PH-1600 form to your local health department or fax to the state health office at (615) 741-3857

• Send automatically via electronic case reporting (eCR). See this TDH webpage for more information on eCR, register at the Trader Partner Registration website, or contact MU.Health@tn.gov for assistance.

• Submit online via NBS. NBS is TDH's reportable disease system. To request an NBS account for reporting Complete this user survey to request an NBS account for reporting

• Blood lead levels can be sent via fax ( (615) 741-3857), entered online, or reported using the instructions at this link

Information about this Reportable Disease for the Public

What It Is

A contagious viral infection caused by the mumps virus. It mainly affects the salivary (parotid) glands near the jaw. Spreads through saliva or respiratory droplets. Mostly mild but can cause complications in some.. 

Types

No distinct strains causing different disease types.

Cases are classified as sporadic or outbreak-related.

Infections may be typical (with swelling) or atypical (mild/no swelling).

Vaccinated people can still get milder infections.

Signs and Symptoms

Fever, headache, muscle aches, and fatigue.

Painful swelling of one or both parotid glands.

Loss of appetite and difficulty chewing or swallowing.

Complications include orchitis, meningitis, or hearing loss.

Treatment

No specific antiviral treatment available.

Use rest, fluids, and pain or fever reducers.

Apply warm or cold compresses to swollen areas.

Preventable through the MMR (measles-mumps-rubella) vaccine.

This Page Last Updated: March 25, 2026 at 8:53 PM